Anne-Marte Bakken Kran
- Associate professor; MD, PhD
- +47 221 18 504
Publications 2024
No association between disease severity and respiratory syncytial virus subtypes RSV-A and RSV-B in hospitalized young children in Norway
PLoS One, 19 (3), e0298104
DOI 10.1371/journal.pone.0298104, PubMed 38466702
Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B
Aliment Pharmacol Ther, 60 (4), 434-445
DOI 10.1111/apt.18147, PubMed 38970293
Emergence of enterovirus D68 in a Norwegian paediatric population 2012-2022
Frontiers in Virology, 4, 1-7
DOI 10.3389/fviro.2024.1358963, PublikaID 493
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults
BMC Infect Dis, 24 (1), 841
DOI 10.1186/s12879-024-09670-w, PubMed 39164637
Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies
Harm Reduct J, 21 (1), 120
DOI 10.1186/s12954-024-01023-9, PubMed 38890611
Publications 2023
Convalescent plasma from Norwegian blood donors to treat COVID-19
Tidsskr Nor Laegeforen, 143 (11)
DOI 10.4045/tidsskr.22.0180, PubMed 37589362
Publications 2022
Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21
Euro Surveill, 27 (13)
DOI 10.2807/1560-7917.ES.2022.27.13.2100376, PubMed 35362405
The burden of hospital-attended influenza in Norwegian children
Front Pediatr, 10, 963274
DOI 10.3389/fped.2022.963274, PubMed 36160779
Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age
Front Pediatr, 10, 1004739
DOI 10.3389/fped.2022.1004739, PubMed 36110112
Corrigendum to 'The burden of respiratory syncytial virus in children under 5 years of age in Norway' [Journal of Infection Volume 84, Issue 2 (2022) Pages 205-215]
J Infect, 86 (4), 420
DOI 10.1016/j.jinf.2022.12.018, PubMed 36572618
Duodenal inflammation in common variable immunodeficiency has altered transcriptional response to viruses
J Allergy Clin Immunol, 151 (3), 767-777
DOI 10.1016/j.jaci.2022.09.029, PubMed 36220400
COVID-19 convalescent plasma from Norwegian blood donors
Tidsskr Nor Laegeforen, 142 (9)
DOI 10.4045/tidsskr.22.0057, PubMed 35699539
Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021
Influenza Other Respir Viruses, 16 (6), 1004-1013
DOI 10.1111/irv.13024, PubMed 35770841
Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014-2018
Infect Dis (Lond), 54 (5), 367-377
DOI 10.1080/23744235.2021.2022196, PubMed 34983302
Publications 2021
Impact of the Rotavirus Vaccination Program in Norway After Four Years With High Coverage
Pediatr Infect Dis J, 40 (4), 368-374
DOI 10.1097/INF.0000000000003020, PubMed 33399430
The burden of respiratory syncytial virus in children under 5 years of age in Norway
J Infect, 84 (2), 205-215
DOI 10.1016/j.jinf.2021.12.008, PubMed 34906596
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort
J Clin Virol, 137, 104789
DOI 10.1016/j.jcv.2021.104789, PubMed 33736946
Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic
Influenza Other Respir Viruses, 16 (2), 204-212
DOI 10.1111/irv.12932, PubMed 34751488
Publications 2020
Field performance of HBsAg rapid diagnostic tests in rural Ethiopia
J Virol Methods, 289, 114061
DOI 10.1016/j.jviromet.2020.114061, PubMed 33388369
Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
Clin Chem Lab Med, 58 (9), 1595-1600
DOI 10.1515/cclm-2020-0628, PubMed 32598303
Publications 2019
HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
BMC Med, 17 (1), 4
DOI 10.1186/s12916-018-1241-1, PubMed 30616632
To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
BMC Infect Dis, 19 (1), 80
DOI 10.1186/s12879-018-3570-2, PubMed 30669985
Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning
Sci Rep, 9 (1), 16158
DOI 10.1038/s41598-019-52570-2, PubMed 31695095
Publications 2018
Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort
AIDS, 32 (2), 161-169
DOI 10.1097/QAD.0000000000001689, PubMed 29112061
High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
J Neuroinflammation, 15 (1), 327
DOI 10.1186/s12974-018-1366-3, PubMed 30470234
Stratification by interferon-γ release assay level predicts risk of incident TB
Thorax, 73 (7), 652-661
DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693
Publications 2016
A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
Am J Gastroenterol, 111 (10), 1467-1475
DOI 10.1038/ajg.2016.329, PubMed 27527747
Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests
J Clin Microbiol, 54 (10), 2521-9
DOI 10.1128/JCM.00346-16, PubMed 27466385
Publications 2015
Primary resistance to integrase strand-transfer inhibitors in Europe
J Antimicrob Chemother, 70 (10), 2885-8
DOI 10.1093/jac/dkv202, PubMed 26188038
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
Clin Infect Dis, 62 (5), 655-663
DOI 10.1093/cid/civ963, PubMed 26620652
Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014
Euro Surveill, 20 (10), 21062
DOI 10.2807/1560-7917.es2015.20.10.21062, PubMed 25788251
Publications 2014
High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014
Influenza Other Respir Viruses, 9 (2), 59-63
DOI 10.1111/irv.12300, PubMed 25534826
[Local food at exotic vacation]
Tidsskr Nor Laegeforen, 134 (2), 192-3
DOI 10.4045/tidsskr.13.1372, PubMed 24477156
Comparable Cellular Immune Responses in Patients with and without Antiretroviral Treatment after Immunization with HIV-1 P24, P17 and Tat Consensus Peptides (Vacc-5q)
J AIDS Clin Res, 5 (4), 1000294
DOI 10.4172/2155-6113.1000296, PublikaID 217
Publications 2013
Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration
PLoS One, 8 (7), e71174
DOI 10.1371/journal.pone.0071174, PubMed 23936260
Publications 2012
Infectious encephalitis: a description of a Norwegian cohort
Scand J Infect Dis, 45 (3), 179-85
DOI 10.3109/00365548.2012.719634, PubMed 23113672
Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts
Clin Infect Dis, 56 (6), 888-97
DOI 10.1093/cid/cis1000, PubMed 23223594
Publications 2011
Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
BMC Infect Dis, 11, 75
DOI 10.1186/1471-2334-11-75, PubMed 21435254
Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
APMIS, 120 (3), 204-9
DOI 10.1111/j.1600-0463.2011.02843.x, PubMed 22339677
Publications 2010
Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
AIDS, 24 (17), 2609-18
DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558
Publications 2009
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
J Clin Microbiol, 47 (7), 2170-4
DOI 10.1128/JCM.00519-09, PubMed 19420166
Publications 2006
[Immunopathogenesis and therapeutic immunization in HIV-infection]
Tidsskr Nor Laegeforen, 126 (23), 3112-6
PubMed 17160117
Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
AIDS, 20 (4), 627-30
DOI 10.1097/01.aids.0000210620.75707.ac, PubMed 16470131
Peptide-based therapeutic immunizations targeting dendritic cells in chronic HIV-1 infection
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 402, 1 b. (flere pag.)
BIBSYS 060843748, ISBN 82-8080-169-3
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
AIDS, 20 (6), 813-20
DOI 10.1097/01.aids.0000218544.54586.f1, PubMed 16549964
Publications 2005
Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
Vaccine, 23 (31), 4011-5
DOI 10.1016/j.vaccine.2005.03.010, PubMed 15963359
Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia
AIDS, 19 (6), 563-7
DOI 10.1097/01.aids.0000163932.76531.c6, PubMed 15802974
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
Vaccine, 24 (10), 1543-50
DOI 10.1016/j.vaccine.2005.10.012, PubMed 16289707
Publications 2004
HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
AIDS, 18 (14), 1875-83
DOI 10.1097/00002030-200409240-00003, PubMed 15353973